1. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012;380:1590-1605.PMID:
22914295.
2. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.e42.PMID:
22001864.
3. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158-165.e2.PMID:
23583432.
4. Ouyang Q, Wang YF, Hu RW. Epidemiology of inflammatory bowel disease in China. Chung Hua Hsiao Hua Tsa Chih 2008;28:814-818.
5. Zeng Z, Zhu Z, Yang Y, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong province, China: a prospective population-based study. J Gastroenterol Hepatol 2013;28:1148-1153.PMID:
23432198.
6. Zhao J, Ng SC, Lei Y, et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "Western" disease. Inflamm Bowel Dis 2013;19:1839-1845.PMID:
23669403.
7. Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis 2012;6:991-1030.PMID:
23040451.
8. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984;25:665-672.PMID:
6735250.
9. Frolkis AD, Dykeman J, Negrón ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 2013;145:996-1006.PMID:
23896172.
10. Li XF, Lu FG, Zou YY, Ouyang CH, Ye LJ, Wang ZG. Analysis of clinical characteristics of 43 surgical patients with Crohn disease using the Montreal classification. Zhonghua Wei Chang Wai Ke Za Zhi 2010;13:210-212.PMID:
20336541.
11. Zhou J, Wang JP, Wang J, et al. Analysis of surgical treatment of Crohn's disease: a report of 85 cases. Chin J Pract Surg 2007;27:211-213.
12. Pan Y, Ouyang Q, Hu RW. Analysis of surgical treatment for severe ulcerative colitis. Zhonghua Wei Chang Wai Ke Za Zhi 2010;13:430-432.PMID:
20577922.
13. Inflammatory Bowel Disease Cooperation Group of China. Wang YF, Ouyang Q. A retrospective study of 3100 inpatients with ulcerative colitis in China. Chung Hua Hsiao Hua Tsa Chih 2006;26:368-372.
14. Bernstein CN, Loftus EV Jr, Ng SC, Lakatos PL, Moum B. Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD). Hospitalisations and surgery in Crohn's disease. Gut 2012;61:622-629.PMID:
22267595.
15. Gao X, Yang RP, Chen MH, et al. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease. Scand J Gastroenterol 2012;47:1181-1191.PMID:
22845663.
17. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955;2:1041-1048.PMID:
13260656.
18. Inflammatory Bowel Disease Cooperation Group of China. Recommendation of inflixmab treatment for Crohn's disease. Chung Hua Hsiao Hua Tsa Chih 2008;28:847-849.
19. Li SR, Lu XJ, Sheng JQ, Fan J, Li S, Zhao X. Comparison of the treating effects of infliximab in Crohn's disease and ulcerative colitis. Weichangbingxue He Ganbingxue Zazhi 2010;19:644-647.
20. Sun YY, Wu YF, Xu C, et al. Efficacy of infliximab in treatment of patients with Crohn's disease. Acad J Second Mil Med Univ 2010;31:338-339.
21. Wang YJ, Li ZY, Sun L, Peng Q, Liu L. Clinical observation for the combination of intestinal probiotics and infliximab in treatment of refractory Crohn's disease. China Mod Dr 2010;(22): 119.
22. Wu DP, Zheng P. Efficacy infliximab of treatment in 11 patients with Crohn's disease. Int J Dig Dis 2010;30:314-318.
23. Zhou AC, Jin HY. Application of infliximab in treating Crohn's disease. Med Recapitulate 2010;16:3786-3788.
24. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004;10:646-651.PMID:
15472528.
25. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 2006;12:212-217.PMID:
16534423.
26. Brant SR, Nguyen GC. Is there a gender difference in the prevalence of Crohn's disease or ulcerative colitis? Inflamm Bowel Dis 2008;14(Suppl 2): S2-S3.PMID:
18816735.
27. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916-924.PMID:
10342800.
28. Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 2013;62:630-649.PMID:
23335431.
29. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274-1282.PMID:
16771949.
30. Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93: a prospective population-based study: the Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of gastroenterologists. Scand J Gastroenterol 1996;31:362-366.PMID:
8726304.
31. Lehtinen P, Ashorn M, Iltanen S, et al. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-2003, a nationwide study. Inflamm Bowel Dis 2011;17:1778-1783.PMID:
21744433.
32. Yang H, Li Y, Wu W, et al. The incidence of inflammatory bowel disease in Northern China: a prospective population-based study. PLoS One 2014;9:e101296PMID:
10.1371/journal.pone.0101296. PMID:
25029440.
33. Infections Bowel. The consensus on diagnosis and management of inflammatory bowel disease (2012 Guangzhou). Chin J Gastroenterol 2012;(12): 763-781.
34. Rungoe C, Langholz E, Andersson M, et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 2014;63:1607-1616.PMID:
24056767.
35. Clemente V, Aratari A, Papi C, Vernia P. Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years: has something changed? Dig Liver Dis 2016;48:371-375.PMID:
26854257.
36. Caprilli R, Viscido A, Latella G. Current management of severe ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2007;4:92-101.PMID:
17268544.
37. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg 2000;87:1697-1701.PMID:
11122187.
38. Michelassi F, Melis M, Rubin M, Hurst RD. Surgical treatment of anorectal complications in Crohn's disease. Surgery 2000;128:597-603.PMID:
11015093.
39. Han Y, Lin MB, He YG, et al. Laparoscopic surgery for inflammmatory bowel disease: the experience in China. J Invest Surg 2013;26:180-185.PMID:
23514051.
40. Fazio VW, Marchetti F. Recurrent Crohn's disease and resection margins: bigger is not better. Adv Surg 1999;32:135-168.PMID:
9891742.
41. Dietz DW, Laureti S, Strong SA, et al. Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn's disease. J Am Coll Surg 2001;192:330-337.PMID:
11245375.
42. Cohen JL, Strong SA, Hyman NH, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum 2005;48:1997-2009.PMID:
16258712.
43. Camilleri-Brennan J, Munro A, Steele RJ. Does an ileoanal pouch offer a better quality of life than a permanent ileostomy for patients with ulcerative colitis? J Gastrointest Surg 2003;7:814-819.PMID:
13129563.
44. MacLean AR, Cohen Z, MacRae HM, et al. Risk of small bowel obstruction after the ileal pouch-anal anastomosis. Ann Surg 2002;235:200-206.PMID:
11807359.
45. Heuschen UA, Hinz U, Allemeyer EH, et al. Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg 2002;235:207-216.PMID:
11807360.
46. Galandiuk S, Scott NA, Dozois RR, et al. Ileal pouch-anal anastomosis: reoperation for pouch-related complications. Ann Surg 1990;212:446-452.PMID:
2171442.
47. Oussalah A, Evesque L, Laharie D, et al. A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization. Am J Gastroenterol 2010;105:2617-2625.PMID:
20736936.